重症心肌炎的早期识别和救治

袁璟. 重症心肌炎的早期识别和救治[J]. 临床心血管病杂志, 2021, 37(2): 97-100. doi: 10.13201/j.issn.1001-1439.2021.02.001
引用本文: 袁璟. 重症心肌炎的早期识别和救治[J]. 临床心血管病杂志, 2021, 37(2): 97-100. doi: 10.13201/j.issn.1001-1439.2021.02.001
YUAN Jing. Early recognition and emergency treatment for fulminant myocarditis[J]. J Clin Cardiol, 2021, 37(2): 97-100. doi: 10.13201/j.issn.1001-1439.2021.02.001
Citation: YUAN Jing. Early recognition and emergency treatment for fulminant myocarditis[J]. J Clin Cardiol, 2021, 37(2): 97-100. doi: 10.13201/j.issn.1001-1439.2021.02.001

重症心肌炎的早期识别和救治

  • 基金项目:

    国家自然科学基金面上项目(No:81770378)

详细信息
    通讯作者: 袁璟,E-mail:yhelen13@163.com
  • 中图分类号: R542.2

Early recognition and emergency treatment for fulminant myocarditis

More Information
  • 急性重症心肌炎(acute fulminant myocarditis,AFM)早期识别和救治是提高患者生存率和改善预后的关键。目前尚无明确的AFM诊断标准,近年研究显示,重视成人AFM的年龄分布、关注常见临床类型的特征性表现和针对性治疗、尽早采取改善血流动力学措施以及加强随访,对减少患者死亡有重要意义。
  • 加载中
  • [1]

    Sharma AN,Stultz JR,Bellamkonda N,et al.Fulminant myocarditis:epidemiology,pathogenesis,diagnosis,and management[J].Am J Cardiol,2019,124(12):1954-1960.

    [2]

    Ammirati E,Veronese G,Bottiroli M,et al.Update on acute myocarditis[J].Trends Cardiovasc Med,2020,S1050-1738(20):30079-7.

    [3]

    Matsuura H,Ichida F,Saji TM,et al.Clinical features of acute and fulminant myocarditis in children-2nd Nationwide Survey by Japanese Society of Pediatric Cardiology and Cardiac Surgery[J].Circ J,2016,80:2362-2368.

    [4]

    Ammirati E,Cipriani M,Lilliu M,et al.Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis[J].Circulation,2017,136(6):529-545.

    [5]

    Yang H,Lu Y,Yang H,et al.Clinical characteristics and treatment effects of astragalus injection in non-pediatric patients with acute fulminant myocarditis[J].Medicine(Baltimore),2020,99(48):e23062.

    [6]

    Arola A,Pikkarainen E,Sipila JO,et al.Occurrence and features of childhood myocarditis:a nationwide study in Finland[J].J Am Heart Assoc,2017,6(11):e005306.

    [7]

    Schubert S,Opgen-Rhein B,Boehne M,et al.Severe heart failure and the need for mechanical circulatory support and heart transplantation in pediatric patients with myocarditis:Results from the prospective multicenter registry "MYKKE"[J].Pediatr Transpl,2019,23(7):e13548.

    [8]

    Kyto V,Sipila J,Rautava P.The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood[J].Heart,2013,99(22):1681-1684.

    [9]

    Ammirati E,Veronese G,Brambatti M,et al.Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction[J].J Am Coll Cardiol,2019,74(3):299-311.

    [10]

    Kociol RD,Cooper LT,Fang JC,et al.Recognition and initial management of fulminant myocarditis:a scientific statement from the American Heart Association[J].Circulation,2020,141(6):e69-e92.

    [11]

    Aquaro GD,Perfetti M,Camastra G,et al.Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function:ITAMY Study[J].J Am Coll Cardiol,2017,70(16):1977-1987.

    [12]

    Caforio AL,Pankuweit S,Arbustini E,et al.Current state of knowledge on aetiology,diagnosis,management,and therapy of myocarditis:a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases[J].Eur Heart J,2013,34(33):2636-2648.

    [13]

    Moslehi JJ,Salem JE,Sosman JA,et al.Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis[J].Lancet,2018,391(10124):933.

    [14]

    Oudemans-van Straaten HM,Spoelstra-de Man AM,de Waard MC.Vitamin C revisited[J].Crit Care,2014,18(4):460.

    [15]

    Isogai T,Yasunaga H,Matsui H,et al.Effect of intravenous immunoglobulin for fulminant myocarditis on in-hospital mortality:propensity score analyses[J].J Card Fail,2015,21(5):391-397.

    [16]

    Kühl U,Lassner D,Von Schlippenbach J,et al.Interferon-Beta improves survival in enterovirus-associated cardiomyopathy[J].J Am Coll Cardiol,2012,60(14):1295-1296.

    [17]

    Lorusso R,Centofanti P,Gelsomino S,et al.Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients:a 5-Year multi-institutional experience[J].Ann Thorac Surg,2016,101(3):919-926.

    [18]

    Mccarthy RE,Boehmer JP,Hruban RH,et al.Longterm outcome of fulminant myocarditis as compared with acute(nonfulminant)myocarditis[J].N Engl J Med,2000,342(10):690-695.

  • 加载中
计量
  • 文章访问数:  437
  • PDF下载数:  88
  • 施引文献:  0
出版历程
收稿日期:  2020-12-23

目录